메뉴 건너뛰기




Volumn 12, Issue 8, 2001, Pages 1169-1171

Transformation of Hodgkin's disease to high-grade B-cell lymphoma: Remission after Rituximab monotherapy

Author keywords

B cell lymphoma; CD20 antigen; Hodgkin's disease; Lymphoma; Therapy; Transformation

Indexed keywords

BLEOMYCIN; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IBANDRONIC ACID; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

EID: 0034828364     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011628322057     Document Type: Article
Times cited : (9)

References (15)
  • 15
    • 0033968522 scopus 로고    scopus 로고
    • European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immmunocytoma, and small B-cell lymphocytic lymphoma
    • (2000) J Clin Oncol , vol.18 , pp. 317-324
    • Foran, J.M.1    Rohatiner, A.Z.2    Cunningham, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.